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Myof ascial pain syndrome (MPS) is a common painful disorder of skeletal muscle origin 1 and defined as BSensory, motor, and autonomic symptoms caused by myofascial trigger points (MTrPs).[ 2 MTrPs are hyperirritable spots in the skeletal muscle that are associated with hypersensitive palpable nodules in a taut band and they are found in skeletal muscles involved in maintaining posture, fascia, ligaments, and tendons. 3, 4 They can be divided into either active or latent MTrPs, which are activated by emotional, physical, and metabolic mechanisms.
A wide range of therapeutic interventions are commonly used to manage MPS, including ischemic compression, spray and stretch, strain and counterstrain, trigger point pressure release, transverse friction massage, thermotherapy, ultrasound therapy, low-level laser therapy, transcutaneous electrical nerve stimulation (TENS), and interferential current therapy (IFT). 3,5Y7 A variety of therapeutic interventions are also used to manage MTrPs. Myofascial release techniques are used to relax contracted muscle, stimulate the mechanoreceptors, and increase blood flow and neuron conductance. 7, 8 Exercises are used to reduce muscle tightness and fear of movement, thereby enhancing confidence in independent movements. 7,9Y11 These include stretching, strengthening, and exercises to improve scapular stability and active range of motion (AROM). 7, 12 Exercises to improve AROM are believed to restore normal length and flexibility of muscles. 7 It is claimed that postural advice can prevent recurrent formation of MTrP during and after treatment. 13, 14 Hot packs, ultrasound, spray and stretch techniques, TENS, and IFT are passive physical therapy modalities that are also considered to be important to decrease pain and facilitate healing in managing MTrP. 15 Evidence suggests that hot packs, TENS, or IFT applied over the MTrP alleviates pain and improves range of motion (ROM). 6,7,16Y21 However, evidence suggests that when modalities are given as a single treatment, patients experience immediate but not short-to-long-term improvement. 22,23 Consequently, active physical therapy, passive physical therapy, and postural advice are delivered in combination in an attempt to improve effectiveness, although the effectiveness of this combination therapy is not known.
Evidence suggests that combining active physical therapy with passive physical therapy and postural advice is likely to improve outcomes associated with MPS. 7,16Y18,24Y26 A study by Hou and colleagues 7 evaluated therapeutics combinations of hot pack plus AROM, hot pack plus AROM plus ischemic compression, hot pack plus AROM plus ischemic compression plus TENS, hot pack plus AROM plus stretch with spray, hot pack plus AROM plus stretch with spray plus TENS, and hot pack plus AROM plus IFT and myofascial release. They found that pain and ROM were improved when TENS or IFT was added to combination therapies, although it was difficult to assess the relative contributions of the two modalities because of a lack of standardization of other treatments across groups. Moreover, effects were assessed immediately after treatment in a clinic rather than longer-term with the inclusion of postural advice. The aim of the present study was to compare the effectiveness of TENS and IFT both in a combination of standard care consisting of hot pack, AROM exercise, myofascial release, and a home exercise program in managing MPS patients with MTrPs.
METHODS

Study Design and Setting
The study was a single-blind randomized controlled trial carried out in the service unit of the Department of Physiotherapy, Faculty of Allied Health Sciences, University of Peradeniya, during July 2012 to February 2015. This study compared the effectiveness of TENS with that of standard care, IFT with standard care, and standard care alone (as control intervention) in managing MPS patients with MTrPs. Ethical clearance was obtained from the ethics review committee of the Faculty of Medicine, University of Peradeniya, and the study was registered as a clinical trial with the Sri Lanka Clinical Trial Registry.
Participants
Participants were recruited from patients referred for physiotherapy treatment of MPS and MTrP from the orthopedic clinic and sports medicine clinic of the Teaching Hospital, Peradeniya. Individuals expressing an interest in taking part were given a participant information sheet and were screened for eligibility by the principal investigator, who is a physiotherapy practitioner. Inclusion criteria were patients between 18 and 65 yrs of age who could read and understand a daily newspaper published in the Sinhala language and had at least one unilateral active upper trapezius MTrP, diagnosed by the presence of a sensitive (tender) spot in a palpable taut band with reproduction of pain when the sensitive spot was compressed. 27Y30 Exclusion criteria were patients taking analgesics within 48 hrs before the first physiotherapy treatment and/or patients who had been diagnosed with fibromyalgia, sensory disorders, radiculopathy/myelopathy, disc disease, psychologic disorders, degenerative joint diseases, or fracture or dislocation of the cervical vertebrae. All participants signed a consent form before participating and were aware that they could withdraw from the study at any time without giving a reason.
Data from a pilot study that involved 28 participants were used to calculate the sample size necessary using the G* Power software. 31 Estimates were that to detect a significant difference in the improvement in ROM between two test groups, TENS (mean [SD] improvement, 13.8 [10.1]) and IFT (mean [SD] improvement, 8.1 [4.3]), with a power of 80% (A = 0.2), an alpha at 0.05, and a 10% loss to at follow-up, it would be necessary to enroll 35 patients for each group.
Randomization
It was planned that 105 participants with unilateral shoulder pain caused by at least one MTrP in the upper trapezius muscle would be enrolled onto the study and allocated to one of three treatment interventions using computerized block randomization and allocation group concealed in envelops. The three intervention groups were standard care (control group), standard care and TENS (TENS group), or standard care and IFT (IFT group). The participants were blind to the allocation to treatment groups after randomization, and hence, the study was a single blind trial. The principal investigator acted as both outcome assessor, taking all study measurements, and as therapist administering all study treatment.
Interventions
The intervention period was 4 wks. Participants were asked to attend the clinic two times per week, resulting in a total of eight treatment sessions. 9 A protocol and a study operation manual were developed and a prestudy was conducted to verify whether the measurement procedures and delivery of interventions were feasible. This prestudy involved 15 patients with MPS with at least one upper trapezius MTrP and they were not included in the main trial. During the trial, the interventions were administered during each clinic visit by the principal investigator. The standard care was administered first, which lasted 30 mins, which was followed by 20 mins of TENS or IFT depending on random allocation of patients. In addition, all patients were provided with a home program of selfadministered treatment.
Standard Care (Control) Group
Standard care consisted of hot pack treatment followed by active range of movement (AROM) exercises and myofascial release treatment. A hot pack was placed on the patient_s cervical, paraspinal, and upper thoracic areas (including the upper trapezius muscle with a MTrP) for 20 mins. This was followed by AROM exercise for cervical spine joints. Participants were asked to actively flex the neck so that the head dropped toward the nonpainful (contralateral) trapezius muscles, causing stretch of the affected side. Patients then rotated the head toward the affected (ipsilateral) side. This exercise was repeated five times. Myofascial release was performed with the patient supine and the principal investigator sitting behind the patient_s head. The principal investigator placed her hands on the upper shoulders of the patient and stretched the upper trapezius muscle of the affected side downward and outward. This unilateral stretching and traction of the shoulder portion involving the upper trapezius with the MTrP were applied for 90 to 300 secs until tightness was released. 7, 32 Participants were then provided with advice on correct posture (standing, sitting, sleeping, working) and treatment exercises (AROM, stretching, strengthening, and scapular stability exercises for upper trapezius) to carry out at home each day until the completion of final measurement. 33Y35 For each exercise, the participants were asked to perform one set of 10 repetitions three times a day. The patients were trained on correct posture and how to undertake exercises by the principal investigator at the end of the first treatment session. Participants were checked for competency and any errors in techniques of performing these, and if noted, those were corrected before they were sent home. Participants were asked to maintain a diary of home exercises, and this was checked by the principal investigator at each treatment session.
TENS Group
Patients allocated to TENS first received standard care, including advice for continuing exercises at home. Immediately after the completion of myofascial release, they received 20 mins of TENS administered using a TENS device (SI no. 4270; Technomed Electronics, Tamil Nadu, India) to deliver asymmetrical rectangular biphasic pulsed electrical currents at a pulse repetition frequency (rate) www.ajpmr.com Combined Therapy for Myofascial Trigger Point of 100 Hz and pulse duration (width) of 250 Ksecs. Pulse amplitude was set at a level to produce a strong but nonpainful TENS sensation but without visible or noticeable muscle contraction (i.e., conventional TENS). TENS was administered using a single channel and two electrodes (40 mm Â 50 mm), with the negative electrode (cathode) placed on the MTrP of the upper trapezius muscle and the positive electrode placed on the insertion of acromial tendon 7 (Fig. 1 ).
IFT Group
Patients allocated to IFT first received standard care, including advice for continuing exercises at home. Immediately after completion of myofascial release, they received 20 mins of IFT using a dualchannel IFT device (SI no. 4270; Technomed Electronics). IFT was administered using the quadripolar technique with electrodes placed around the MTrP of the upper trapezius muscle 7 (Fig. 2 ). One channel delivered sinusoidal Bcarrier currents[ at a frequency of 4000 Hz and the other channel delivered currents at a frequency of 4100 Hz. This generated an amplitude modulated interference wave of 100 Hz (i.e., beat frequency). Pulse amplitude was set at a level to produce a strong but nonpainful TENS sensation but without visible or noticeable muscle contraction.
Measurements
All measurements were taken by the principal investigator. Demographic data and history of MPS were collected after enrollment. Cervical ROM and pain intensity were measured at baseline, immediately after the first treatment (within 5 mins), before the eighth treatment, and 1 wk after the eighth treatment. The principal investigator palpated and marked the MTrP. 36 Three measurements of cervical ROMs (cervical extension, cervical rotation to the ipsilateral side, and cervical lateral flexion to the contralateral side) were made using a two-arm portable universal goniometer (DN FORMED Brno,s.p.o, Hudcova 76a, 612 48, Brno-Medlánky). The accuracy and reliability of the universal goniometer to measure cervical movements have been established. 37, 38 The average of the three measurements was used for computations. Pain intensity over the affected upper trapezius at rest was recorded using a 100-mm visual analog scale, with the anchors Bno pain at all[ at 0 mm and Bworst pain imaginable[ at 100 mm. 16,39
Data Processing and Statistics
Statistical Package for Social Science version 19.0 (IBM) for Windows was used for data analysis. Data were examined using explorative statistics, and the distributions were inspected for violations of normality using graphical methods and the Shapiro-Wilk test. Outliers were detected by box plots and further examined using the inter quartile range formula to make sure that they were not extreme values (i.e., any value beyond more than one-and-half times the length of the box [interquartile range]). No extreme values were observed in the data sets. Descriptive statistics of the demographic variables and test measurements were calculated. Cervical ROMs and pain intensity showed acceptable distributions and were analyzed with parametric tests.
Baseline data for cervical ROMs and pain intensity were compared across the three intervention groups using one-way analysis of variance (ANOVA). Change in cervical ROM relative to baseline was calculated by subtracting the baseline data from measurements taken immediately after the first treatment, before the final (eighth) treatment, and 1 wk after the final (eighth) treatment (i.e., 1-wk follow-up). Change in pain intensity was calculated by subtracting measurements taken immediately after the first, before the final (eighth) treatment, and at 1-wk follow-up from the baseline data.
The difference in changes in each outcome relative to the baseline among the three intervention groups were compared using one-way ANOVA with Tukey post hoc tests. Two-sided alpha was defined as 0.05 in accepting statistical significance.
RESULTS
Demographic Data
There were 105 individuals who expressed interest in participating in the study. All completed the study and were entered into the analysis (Fig. 3 ). There were no statistically significant differences in age (F 2,102 = 2.87, P = 0.06, one-way ANOVA) or sex distribution between the groups (Table 1) . A significantly higher proportion of participants had pain on the right trapezius muscle (Table 1) .
Pain Intensity
One-way ANOVA found no significant differences in baseline pain intensity levels reported among the three groups (F 2,102 = 2.96, P = 0.06) ( Table 2 ). There were significant differences among the groups in the changes (reduction) in pain intensities after the first treatment (PI2), before the eighth treatment (PI3), and 1 wk after the eighth treatment (PI4) ( Table 2 ). Post hoc analyses revealed that there was a larger reduction in pain intensity in the TENS group compared with the IFT group after the first treatment (P G 0.05). The reductions in pain intensity in both the TENS and IFT groups were significantly larger compared with the control group (P G 0.05). Similarly, the Tukey tests revealed that there were larger reductions in pain intensity in the TENS group compared with the IFT group in all, during, and postintervention measurements (P G 0.05). Furthermore, there were significantly larger reductions in pain intensity in both the TENS and IFT groups compared with the control group at both of these measurement time points.
Cervical ROM
One-way ANOVA found no significant differences in baseline cervical ROM measurements (i.e., cervical extension, lateral flexion to contralateral side and rotation to ipsilateral side) among the three groups. There were significant differences among the groups in relation to the changes (increase) in cervical ROM after the first treatment (PI2), before the eighth treatment (PI3), and 1 wk after the eighth treatment (PI4) when compared with baseline (Table 3 ). Tukey tests revealed that there was a larger increase in cervical ROM in the TENS group compared with the IFT group after the PI1 indicates pain intensity at baseline; PI2, pain intensity at immediately after the first treatment; PI3, pain intensity at before the eighth treatment; PI4, pain intensity at 1 wk after the eighth treatment. Data are mean T SD. first treatment (P G 0.05). There was a larger increase in cervical ROM in both the TENS and IFT groups compared with the control group (P G 0.05).
Tukey tests further revealed that there were larger increases in cervical ROM in the TENS group compared with the IFT group immediately after the first treatment, before, and 1 wk after the eighth treatment (P G 0.05). There was a larger increase in cervical ROM in both the TENS and IFT groups compared with control at both these occasions.
DISCUSSION
This study found that immediate and shortterm relief of myofascial pain in the upper trapezius can be achieved using a combination of hot pack, AROM exercise, myofascial release, and a home program in patients. Larger immediate and short-term improvements were found for cervical ROM and pain intensity when TENS or IFT was added to this standard care, with TENS producing larger improvements than IFT. It was found that higher proportions of patients experienced MPS in their right trapezius muscles, and this is consistent with previous reports. 40 It has been suggested that differences in muscular activity between the left and right limbs and morphologic differences in the left and right hemibody may contribute to this laterality. 41 Treating MPS and MTrPs using a combined therapeutic approach is not novel. Hou and colleagues 7 claimed that IFT was superior to TENS when added to combination therapy for immediate improvements in cervical myofascial pain and trigger-point sensitivity. However, IFT was combined with hot pack, AROM exercise, and myofascial release, whereas TENS was combined with hot pack, stretch and spray, and AROM exercise. This study built on that of Hou and colleagues 7 by standardizing the combination therapy between groups so that a direct comparison between the addition of IFT or TENS could be made.
The combinations of interventions used in the present study were evidence based and are used as a standard care package within the authors_ clinic. Evidence suggests that hot pack reduces pain and minimizes muscle spasm as a consequence of increased activation of primary afferent fibers. 7,42 AROM exercise causes gentle stretching, which reduces subcutaneous tightness by movements of superficial tissues over deep tissues and thus aiding joint movement. 7 Ma and colleagues 34 compared the effects of miniscalpel-needle release, acupuncture needling, and stretching exercise to trigger point in individuals diagnosed with MPS and did not find improvements in cervical ROM after the 2-wk stretching exercise. In contrast, a randomized controlled trial by Oliveira-Campelo and colleagues 43 found that stretching produced short-and medium term effects on cervical ROM and pressure pain sensitivity in myofascial pain located in the upper trapezius muscle. Stretching exercises are used to reset muscle length, which may be maintained over time using strengthening exercises, scapular stability exercises, and postural awareness. 11, 12, 44 In this study, a home exercise and postural habit program was added in an attempt to sustain any improvements CEX1 indicates cervical extension at baseline; CEX2, cervical extension at immediately after the first treatment; CEX3, cervical extension at before the eighth treatment; CEX4, cervical extension at 1 wk after the eighth treatment; CLFCS1, cervical lateral flexion to the contralateral side at baseline; CLFCS2, cervical lateral flexion to the contralateral side at immediately after the first treatment; CLFCS3, cervical lateral flexion to the contralateral side at before the eighth treatment; CLFCS4, cervical lateral flexion to the contralateral side at 1 wk after the eighth treatment; CRIS1, cervical rotation to the ipsilateral side at baseline; CRIS2, cervical rotation to the ipsilateral side at immediately after the first treatment; CRIS3, cervical rotation to the ipsilateral side at before the eighth treatment; CRIS4, cervical rotation to the ipsilateral side at 1 wk after the eighth treatment. Data are mean T SD.
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Combined Therapy for Myofascial Trigger Point in MTrP symptoms. Reducing the likelihood of reactivating MTrP in the longer term is likely also to decrease anxiety and postural alterations associated with developing MTrP in the future, thus increasing confidence in movement. Moreover, postural habits are known to perpetuate MTrP pain, and the home program in this study may have helped participants to be more aware of their posture during the study period. 45 However, the follow-up was limited to only 1 wk after the final 4-wk treatment session and therefore cannot be considered as a sustained recovery.
The addition of TENS or IFT showed immediate improvements in all outcome measures compared with standard care. Evidence suggests that both TENS and IFT have similar mechanisms of action and, when used in clinical practice for pain relief, may in fact be generating identical physiologic effects. 46 TENS and IFT were delivered at a strong, nonpainful intensity, and this is known to reduce pain by activating low-threshold cutaneous afferents leading to inhibition of nociceptive transmission in the central nervous system (i.e., closing the pain gate). 46 TENS and IFT can improve blood microperfusion and reduce muscle spasms, although evidence for these effects is not consistent. 46 The present study observed larger shortterm increases in cervical ROM and reductions in pain intensity after the addition of TENS than IFT. One possible reason for the superiority of TENS may have been electrode location. TENS was administered with the negative electrode (cathode) over the MTrP and the positive electrode (anode) over the insertion of acromial tendon. This enabled the current to precisely target the MTrP. In contrast, IFT was delivered using four electrodes (tetrapolar/quadripolar technique) placed around the MTrP. No one electrode was located directly over the MTrP, and this may have reduced current density delivered precisely to excitable tissue associated with the MTrP. Although early studies have recommended the bipolar method because it reaches deeper tissues and is more comfortable compared with the tetrapolar manner, 47, 48 Flori and colleagues 49 suggest that the tetrapolar manner is more effective as it produced a higher accommodation threshold.
It is hoped that the findings of the present study will catalyze further studies. There is a need for a fully powered randomized controlled trial on the effectiveness of TENS and IFT for MPS, and data gathered in the present study can be used to calculate sample size. The present study used a unidimensional measurement of pain on a 100-mm visual analog scale, and this captures only a selfreported unidimensional assessment of pain. Thus, future studies should use multidimensional assessment of pain, 50Y52 with treatment goals framed as measureable functional outcomes of daily living because these are more relevant to monitoring progress in the clinical setting and can be verified with quantifiable changes in behavior and quality of life. Furthermore, although performed judiciously, carrying out the clinical procedures and measurements by the principal investigator and not using a placebo for the patients of the control group could be considered as limitations of the present study. Any tools used should also be adapted for a Sri Lankan population. A broader analysis recruiting patients from multiple centers may be useful to generalize the findings to a wider population.
CONCLUSIONS
The addition of TENS or IFT to standard care consisting of a combination of hot pack, AROM exercise, myofascial release, and a home exercise program improved pain and ROM in the immediate term and short-term in individuals with MPS. The findings suggested that TENS was superior to IFT. 
